An elderly adult stands amidst a heatwave.

Turning the tide of early cancer detection

Next-generation liquid biopsy technologies that detect fragments of circulating cell-free tumor DNA could be a game-changer in early cancer detection.


  • People of different ages and backgrounds coming together to form a healthy population

    Women’s health has been underfunded and underprioritized for too long, leading to delays in diagnosis and poor health outcomes. This series will bring together a range of viewpoints and new research focusing on the causes of ill health in women and the barriers to their health and wellbeing in the 21st Century.

  • Africa

    Join us for this free-to-attend, in-person conference in Nairobi, Kenya, catalyzing collaboration and driving change. Attendees will delve into cutting-edge scientific breakthroughs surrounding the epidemiology of dementia, the contributing risk factors and genetics, and advancements in early detection and diagnosis of dementia in Africa and globally.

  • dei series

    This ongoing series brings together a range of viewpoints on DEI in medical research, covering topics such as funding biases, workforce diversity and how to fix the lack of diversity of health data. Reach out to us to contribute your perspective.

Nature Medicine is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


    • Accumulating data support the systemic benefits of semaglutide (and potentially other GLP-1RA-based therapies) in people with obesity, meaning that cardiologists and other clinicians must become familiar with prescribing them — particularly once market competition makes these drugs more accessible.

      • Naveed Sattar
      • Matthew M. Y. Lee
      • Darren K. McGuire
      News & Views
    • A longitudinal multiomic dataset was assembled to characterize the immune landscape in myocardial infarction and chronic coronary syndromes. Multiomics factor analysis (MOFA) revealed immune signatures that associate with disease stage or treatment outcomes. This work opens new directions for future mechanistic and clinical studies on coronary artery disease and myocardial infarction.

      Research Briefing
    • Data from a large randomized trial show that a personalized diet can improve cardiometabolic health, providing support for a ‘food as medicine’ concept that, although centuries old, still lacks robust evidence.

      • Josef Neu
      News & Views
    • Dapagliflozin improved a hierarchical composite outcome, including death, a worsening kidney disease event, and estimated glomerular filtration rate slope, compared with placebo, in patients with heart failure. This hierarchical outcome — analyzed with win statistics — might provide the statistical power to evaluate the effect of treatments on kidney function in heart failure trials.

      Research Briefing
    • In an era of expanding perioperative approaches for resectable non–small-cell lung cancer, new data demonstrate that dual neoadjuvant immunotherapy targeting PD-1 and LAG-3 is feasible; future analyses may enhance patient selection by identifying immune signatures predictive of response.

      • Misty D. Shields
      • Christine M. Lovly
      News & Views

Nature Careers

Science jobs